Gelteq Ltd (GELS) CEO details indirect share and note holdings

Rhea-AI Filing Summary

Gelteq Ltd Chief Executive Officer Nathan J. Givoni filed an initial Form 3 reporting indirect holdings in the company through family trusts. The filing lists 657,087 Ordinary Shares held indirectly by trust and a Convertible Note convertible into 15,000 Ordinary Shares at an exercise price of $2.0000 per share, expiring on July 1, 2026. A footnote explains he has shared investment authority as a manager of the trustee entity and is a co-beneficiary, and he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Givoni Nathan J

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Convertible Note	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Convertible Note — 15,000 shares (Indirect, By Trust); Ordinary Shares — 657,087 shares (Indirect, By Trust)

Footnotes (1)

1. The reporting person has shared investment authority as a manager of the trustee entity of certain family trusts holding shares of the Issuer, and is a co-beneficiary of such trusts. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Convertible Note was issued in March 2026 in the principal amount of AUD$30,000.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Givoni Nathan J

(Last) (First) (Middle)

C/O GELTEQ LIMITED

LEVEL 19 644 CHAPEL ROAD

(Street)

SOUTH YARRA 3141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Gelteq Ltd [ GELS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	657,087	I	By Trust(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible Note	07/01/2026	07/01/2026	Ordinary Shares	15,000(2)	$2	I	By Trust(1)

Explanation of Responses:

1. The reporting person has shared investment authority as a manager of the trustee entity of certain family trusts holding shares of the Issuer, and is a co-beneficiary of such trusts. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

2. The Convertible Note was issued in March 2026 in the principal amount of AUD$30,000.

	/s/ Nathan J. Givoni	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Gelteq Ltd (GELS) CEO report on this Form 3 filing?

The CEO reports indirect holdings in Gelteq Ltd through family trusts. These include 657,087 Ordinary Shares and a Convertible Note into 15,000 Ordinary Shares, reflecting his initial beneficial ownership position as an officer of the company.

How many Gelteq Ltd (GELS) shares are reported as indirectly held by trust?

The filing reports 657,087 Ordinary Shares of Gelteq Ltd held indirectly by trust. These are attributed to family trusts where the CEO has shared investment authority and is a co-beneficiary, subject to his pecuniary interest.

What are the key terms of the Gelteq Ltd (GELS) Convertible Note disclosed?

The Convertible Note is in a principal amount of AUD$30,000 and is convertible into 15,000 Ordinary Shares at $2.0000 per share. It has an exercise and expiration date of July 1, 2026, and is held indirectly via a trust.

Are the Gelteq Ltd (GELS) securities held directly by the CEO?

No, the securities are reported as held indirectly by trust. The CEO has shared investment authority as a manager of the trustee entity, is a co-beneficiary, and disclaims beneficial ownership except to the extent of his pecuniary interest.

Does this Gelteq Ltd (GELS) Form 3 show insider buying or selling?

The Form 3 does not show insider buying or selling activity. It is an initial statement of beneficial ownership, listing existing indirect holdings in Ordinary Shares and a Convertible Note through family trusts associated with the CEO.